Oral miltefosine to treat new world cutaneous leishmaniasis
Gespeichert in:
Veröffentlicht in: | The Lancet infectious diseases 2007, Vol.7 (1), p.7-7 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 7 |
---|---|
container_issue | 1 |
container_start_page | 7 |
container_title | The Lancet infectious diseases |
container_volume | 7 |
creator | Soto, Jaime Toledo, Julia T |
description | |
doi_str_mv | 10.1016/S1473-3099(06)70665-X |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_201606376</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S147330990670665X</els_id><sourcerecordid>1665937781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-c22173dfec307d29fd75b55c9df37f08c5d48b8590bf9c59dd002488858f3fa83</originalsourceid><addsrcrecordid>eNqFkMFq3DAQhkVJaJJtH6HB5NQcnIwsy5IJpJTQJoGFPTSBvQmtNCJKvfZWsrPk7au1lxZyyWmE-OebmY-QLxQuKNDq8hctBcsZ1PVXqM4FVBXPlx_Icfou87Lk4mB8T5EjchLjMwAVFMqP5ChVWTAmj8nVIugmW_umR9dF32LWd1kfUPdZi9ts24XGZmbodYvdELMGfXxa69br6OMncuh0E_Hzvs7I488fDzd3-Xxxe3_zfZ6btEefm6KgglmHhoGwRe2s4CvOTW0dEw6k4baUK8lrWLna8NpagKKUUnLpmNOSzcjZxN2E7s-AsVfP3RDaNFIVSQVUTFQpxKeQCV2MAZ3aBL_W4VVRUDtjajSmdjoUVGo0ppap73QPH1ZrtP-79opS4NsUwHTii8egovHYGrQ-oOmV7fy7I67fEEzjW2908xtfMf47hqpYKJggOwZUI2HJ_gLuio_M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201606376</pqid></control><display><type>article</type><title>Oral miltefosine to treat new world cutaneous leishmaniasis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central UK/Ireland</source><creator>Soto, Jaime ; Toledo, Julia T</creator><creatorcontrib>Soto, Jaime ; Toledo, Julia T</creatorcontrib><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(06)70665-X</identifier><identifier>PMID: 17182338</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Administration, Oral ; Animals ; Antiprotozoal Agents - administration & dosage ; Antiprotozoal Agents - adverse effects ; Antiprotozoal Agents - therapeutic use ; Humans ; Infectious Disease ; Infectious diseases ; Leishmania braziliensis - drug effects ; Leishmaniasis, Cutaneous - drug therapy ; Phosphorylcholine - administration & dosage ; Phosphorylcholine - adverse effects ; Phosphorylcholine - analogs & derivatives ; Phosphorylcholine - therapeutic use ; Vector-borne diseases</subject><ispartof>The Lancet infectious diseases, 2007, Vol.7 (1), p.7-7</ispartof><rights>Elsevier Ltd</rights><rights>2007 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Jan 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-c22173dfec307d29fd75b55c9df37f08c5d48b8590bf9c59dd002488858f3fa83</citedby><cites>FETCH-LOGICAL-c445t-c22173dfec307d29fd75b55c9df37f08c5d48b8590bf9c59dd002488858f3fa83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/201606376?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,3536,4009,27902,27903,27904,45974,64362,64366,72216</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17182338$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Soto, Jaime</creatorcontrib><creatorcontrib>Toledo, Julia T</creatorcontrib><title>Oral miltefosine to treat new world cutaneous leishmaniasis</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><subject>Administration, Oral</subject><subject>Animals</subject><subject>Antiprotozoal Agents - administration & dosage</subject><subject>Antiprotozoal Agents - adverse effects</subject><subject>Antiprotozoal Agents - therapeutic use</subject><subject>Humans</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Leishmania braziliensis - drug effects</subject><subject>Leishmaniasis, Cutaneous - drug therapy</subject><subject>Phosphorylcholine - administration & dosage</subject><subject>Phosphorylcholine - adverse effects</subject><subject>Phosphorylcholine - analogs & derivatives</subject><subject>Phosphorylcholine - therapeutic use</subject><subject>Vector-borne diseases</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkMFq3DAQhkVJaJJtH6HB5NQcnIwsy5IJpJTQJoGFPTSBvQmtNCJKvfZWsrPk7au1lxZyyWmE-OebmY-QLxQuKNDq8hctBcsZ1PVXqM4FVBXPlx_Icfou87Lk4mB8T5EjchLjMwAVFMqP5ChVWTAmj8nVIugmW_umR9dF32LWd1kfUPdZi9ts24XGZmbodYvdELMGfXxa69br6OMncuh0E_Hzvs7I488fDzd3-Xxxe3_zfZ6btEefm6KgglmHhoGwRe2s4CvOTW0dEw6k4baUK8lrWLna8NpagKKUUnLpmNOSzcjZxN2E7s-AsVfP3RDaNFIVSQVUTFQpxKeQCV2MAZ3aBL_W4VVRUDtjajSmdjoUVGo0ppap73QPH1ZrtP-79opS4NsUwHTii8egovHYGrQ-oOmV7fy7I67fEEzjW2908xtfMf47hqpYKJggOwZUI2HJ_gLuio_M</recordid><startdate>2007</startdate><enddate>2007</enddate><creator>Soto, Jaime</creator><creator>Toledo, Julia T</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>2007</creationdate><title>Oral miltefosine to treat new world cutaneous leishmaniasis</title><author>Soto, Jaime ; Toledo, Julia T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-c22173dfec307d29fd75b55c9df37f08c5d48b8590bf9c59dd002488858f3fa83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Administration, Oral</topic><topic>Animals</topic><topic>Antiprotozoal Agents - administration & dosage</topic><topic>Antiprotozoal Agents - adverse effects</topic><topic>Antiprotozoal Agents - therapeutic use</topic><topic>Humans</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Leishmania braziliensis - drug effects</topic><topic>Leishmaniasis, Cutaneous - drug therapy</topic><topic>Phosphorylcholine - administration & dosage</topic><topic>Phosphorylcholine - adverse effects</topic><topic>Phosphorylcholine - analogs & derivatives</topic><topic>Phosphorylcholine - therapeutic use</topic><topic>Vector-borne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soto, Jaime</creatorcontrib><creatorcontrib>Toledo, Julia T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soto, Jaime</au><au>Toledo, Julia T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral miltefosine to treat new world cutaneous leishmaniasis</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2007</date><risdate>2007</risdate><volume>7</volume><issue>1</issue><spage>7</spage><epage>7</epage><pages>7-7</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><coden>LANCAO</coden><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>17182338</pmid><doi>10.1016/S1473-3099(06)70665-X</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1473-3099 |
ispartof | The Lancet infectious diseases, 2007, Vol.7 (1), p.7-7 |
issn | 1473-3099 1474-4457 |
language | eng |
recordid | cdi_proquest_journals_201606376 |
source | MEDLINE; Elsevier ScienceDirect Journals; ProQuest Central UK/Ireland |
subjects | Administration, Oral Animals Antiprotozoal Agents - administration & dosage Antiprotozoal Agents - adverse effects Antiprotozoal Agents - therapeutic use Humans Infectious Disease Infectious diseases Leishmania braziliensis - drug effects Leishmaniasis, Cutaneous - drug therapy Phosphorylcholine - administration & dosage Phosphorylcholine - adverse effects Phosphorylcholine - analogs & derivatives Phosphorylcholine - therapeutic use Vector-borne diseases |
title | Oral miltefosine to treat new world cutaneous leishmaniasis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T12%3A33%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20miltefosine%20to%20treat%20new%20world%20cutaneous%20leishmaniasis&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Soto,%20Jaime&rft.date=2007&rft.volume=7&rft.issue=1&rft.spage=7&rft.epage=7&rft.pages=7-7&rft.issn=1473-3099&rft.eissn=1474-4457&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1473-3099(06)70665-X&rft_dat=%3Cproquest_cross%3E1665937781%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=201606376&rft_id=info:pmid/17182338&rft_els_id=1_s2_0_S147330990670665X&rfr_iscdi=true |